SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INCR -- Incara Pharmaceuticals
INCR 1.380+0.5%Nov 6 3:57 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (58)12/24/2000 2:09:55 PM
From: Arthur Radley  Read Replies (1) of 196
 
Rick,
It does appear that Elan has cut a good deal for themselves, but their history shows that they are hardnosed negotiators. With that said.... their expertise and money should speed the process to getting a drug approved.

But as you have pointed out...the thing about INCR that is most exciting is their antioxidant program. My feeble brain(probably the lack of oxygen)couldn't start to calculate the revenue potential for INCR, when one realizes that just here in the "good-old USA", we have approximately 700,000 people annually suffering strokes.

Help me with this statement from their website.."In a model stroke, where the middle cerebral artery of a rat is blocked for 90 minutes and then unblocked, AEOL 10113 reduced damaged brain tissue significantly when introduced as late as 7 1/2 hours after the start of the stroke." Is it realistic to think that in humans they can get the same result after 7 1/2 hours? Would not the average human be dead from such a blockage well before 7 1/2 hours?

Will be interesting to see who INCR might partner this program with. Now that partnership announcement should put a little spark to the share prices!

Thanks for bringing INCR to my attention. I'm looking forward to the market opening on Tuesday...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News